Skip to content
DefDex

Federal award

QUIDELORTHO SALES COMPANY, LLC

W81K0024P0188

Contract

Obligated and Ceiling

Obligated (net)
$508,278.83
Ceiling (potential value, not spending)
$982,686.03
Current value
$508,278.83
Gross positive obligations
$523,640.33

Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.

Award Details

Recipient
QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
Owner company
Not a reviewed companyNo reviewed company owns this recipient.
Reported parent
QUIDELORTHO SALES COMPANY, LLC · ZFXRG96JMJ39
Awarding agency
Department of War · sub-agency 2100 · office W81K00
Funding agency
Department of War · sub-agency 97DH
Product or service (PSC)
6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Industry (NAICS)
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
PIID
W81K0024P0188
Award type code
B
Actions
7 · Aug 19, 2024 to Jun 1, 2026
Why it is listed
gross positive obligations of $100k or more (contracts)

Open this award on USAspending →

Action History7

Award actions
DateFYModAction typeObligationCompany in company totals
Jun 1, 2026FY2026P00006B$12,993.03
—
Jan 27, 2026FY2026P00005C−$15,361.50
—
Dec 15, 2025FY2026P00004J$252,441.10
—
May 8, 2025FY2025P00003G$0.00
—
Mar 28, 2025FY2025P00002C$5,765.10
—
Oct 9, 2024FY2025P00001C$252,441.10
—
Aug 19, 2024FY20240—$0.00
—

Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.